EMJ Hematology 9.2 2021

This review article shares insights from a virtual symposium that took place at the European School of Haematology (ESH) 7th Translational Research e-Conference: Myelodysplastic Syndromes. The three leading speakers have provided a summary of presentations on myelodysplastic syndrome (MDS) treatment, with a focus on precision medicine, the immune and inflammatory microenvironments, and therapies for high-risk cases.